Milestone Pharmaceuticals logo

Milestone Pharmaceuticals Share Price (NASDAQ: MIST)

$1.83

0.02

(1.1%)

Last updated on

Check the interactive Milestone Pharmaceuticals Stock chart to analyse performance

Milestone Pharmaceuticals stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.79
    Today's High:$1.86

    Day's Volatility :3.76%

  • 52 Weeks Low:$0.63
    52 Weeks High:$2.75

    52 Weeks Volatility :77.26%

Milestone Pharmaceuticals Stock Returns

PeriodMilestone Pharmaceuticals IncIndex (Russel 2000)
3 Months
5.78%
0.0%
6 Months
10.91%
0.0%
1 Year
31.65%
0.0%
3 Years
-79.18%
-4.1%

Milestone Pharmaceuticals Inc Key Stats

Check Milestone Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.81
Open
$1.82
Today's High
$1.86
Today's Low
$1.79
Market Capitalization
$153.8M
Today's Volume
$824.9K
52 Week High
$2.75
52 Week Low
$0.6254
Revenue TTM
$0.0
EBITDA
$-54.9M
Earnings Per Share (EPS)
$-0.84
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-780.29%

Stock Returns calculator for Milestone Pharmaceuticals Stock including INR - Dollar returns

The Milestone Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Milestone Pharmaceuticals investment value today

Current value as on today

₹1,36,939

Returns

₹36,939

(+36.94%)

Returns from Milestone Pharmaceuticals Stock

₹31,655 (+31.65%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Milestone Pharmaceuticals Stock

-66%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Milestone Pharmaceuticals Stock from India on INDmoney has decreased by -66% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Milestone Pharmaceuticals Inc

  • Name

    Holdings %

  • RTW INVESTMENTS, LLC

    2.95%

  • Propel Bio Management LLC

    2.11%

  • Alta Fundamental Advisers LLC

    1.65%

  • BML Capital Management LLC

    1.34%

  • Morgan Stanley - Brokerage Accounts

    1.14%

  • Simplify Asset Management Inc.

    1.00%

Analyst Recommendation on Milestone Pharmaceuticals Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Milestone Pharmaceuticals(by analysts ranked 0 to 5 stars)

Milestone Pharmaceuticals Share Price Target

What analysts predicted

Upside of 82.15%

Target:

$3.33

Current:

$1.83

Milestone Pharmaceuticals share price target is $3.33, a slight Upside of 82.15% compared to current price of $1.83 as per analysts' prediction.

Milestone Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, MIST stock has moved up by 7.6%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, -868.00K → 108.0K (in $), with an average increase of 903.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -20.76M → -12.96M (in $), with an average increase of 60.1% per quarter
  • MIST vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 41.0%
  • MIST vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 194.9%

Milestone Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Milestone Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Milestone Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Milestone Pharmaceuticals Inc logo
27.97%
10.91%
31.65%
-79.18%
-77.68%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Organization
Milestone Pharmaceuticals
Employees
33
CEO
Mr. Joseph G. Oliveto M.B.A.
Industry
Pharmaceuticals: Major

Key Management of Milestone Pharmaceuticals Inc

NameTitle
Mr. Joseph G. Oliveto M.B.A.
CEO, President & Director
Mr. Amit Hasija
CFO & Executive VP of Corporate Development
Dr. David B. Bharucha FACC, M.D., Ph.D.
Chief Medical Officer
Dr. Philippe Douville M.B.A., Ph.D.
Founder, Strategic Advisor & Member of Scientific Advisory Board
Mr. Jeffrey Nelson
Chief Operating Officer
Mr. Roshan Girglani
Vice President of Marketing
Mr. Jeff Moore
Vice President of Sales
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.
Chief Medical Advisor & Member of the Scientific Advisory Board
Dr. Guy Rousseau
SVP of Regulatory Affairs and Quality Management
Mr. Lorenz Muller
Chief Commercial Officer

Important FAQs about investing in MIST Stock from India :

What is Milestone Pharmaceuticals share price today?

Milestone Pharmaceuticals share price today is $1.83 as on at the close of the market. Milestone Pharmaceuticals share today touched a day high of $1.86 and a low of $1.79.

What is the 52 week high and 52 week low for Milestone Pharmaceuticals share?

Milestone Pharmaceuticals share touched a 52 week high of $2.75 and a 52 week low of $0.63. Milestone Pharmaceuticals stock price today i.e. is closed at $1.83, lower by 33.45% versus the 52 week high.

How to invest in Milestone Pharmaceuticals Stock (MIST) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Milestone Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Milestone Pharmaceuticals Shares that will get you 0.8197 shares as per Milestone Pharmaceuticals share price of $1.83 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Milestone Pharmaceuticals Stock (MIST) from India?

Indian investors can start investing in Milestone Pharmaceuticals (MIST) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Milestone Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Milestone Pharmaceuticals share’s latest price of $1.83 as on August 30, 2025 at 1:29 am IST, you will get 5.4645 shares of Milestone Pharmaceuticals. Learn more about fractional shares .

What are the returns that Milestone Pharmaceuticals has given to Indian investors in the last 5 years?

Milestone Pharmaceuticals stock has given -77.68% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?